Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Shares Outstanding (2025 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) posted Weighted Average Shares Outstanding of 46.71 million for Q3 2026, compared with 946,000 a year earlier and up 55.1% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Shares Outstanding (2025 - 2026) Analysis & Trends

For FY2025, Hemab Therapeutics Holdings' Weighted Average Shares Outstanding came in at 946,000.

  • According to Business Quant data, Weighted Average Shares Outstanding for the three prior quarters was 30.11 million (Q2 2026), 946,000 (Q1 2026) and 946,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 1.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 1.94 Bn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.70 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 46.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 46.71 Mn
Jun 30, 2026 30.11 Mn
Mar 31, 2026 946,000.00
Dec 31, 2025 946,000.00
Sep 30, 2025 946,000.00
Jun 30, 2025 946,000.00
Mar 31, 2025 946,000.00
API Access

Hemab Therapeutics Holdings Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=COAG&period=max&api_key=YOUR_API_KEY